Triethylamine → Ammonium Hydroxide

HRID 1630915Notes

Reaction equation

HRID 1630915 reaction equation
[NH2:1][CH2:2][C:3]1[CH:4]=[C:5]([C:9]2[N:10]([CH3:21])[C:11]3[C:16]([C:17]=2[C:18]#[N:19])=[CH:15][CH:14]=[C:13]([Cl:20])[CH:12]=3)[CH:6]=[N:7][CH:8]=1.C(N(N[S:28](Cl)(=[O:30])=[O:29])CC)C.[CH2:32]([N:34](CC)[CH2:35][CH3:36])[CH3:33]>ClCCl>[NH4+:1].[OH-:29].[CH2:32]([N:34]([CH2:35][CH3:36])[S:28]([NH:1][CH2:2][C:3]1[CH:8]=[N:7][CH:6]=[C:5]([C:9]2[N:10]([CH3:21])[C:11]3[C:16]([C:17]=2[C:18]#[N:19])=[CH:15][CH:14]=[C:13]([Cl:20])[CH:12]=3)[CH:4]=1)(=[O:30])=[O:29])[CH3:33]

Participants

6

Procedure

A flask is charged with 2-(5-aminomethyl-pyridin-3-yl)-6-chloro-1-methyl-1H-indole-3-carbonitrile (Example 186e, 0.103 g, 0.349 mmol) and dichloromethane (2 mL). Diethylaminosulfamoyl chloride (0.072 g, 0.419 mmol) and triethylamine (0.100 mL, 0.699 mmol) are added and the reaction is stirred at room temperature overnight. The reaction mixture is concentrated in vacuo and the residue is purified by reverse phase HPLC with Xbridge Shield RP18 column and a 0.1% aqueous NH4OH in acetonitrile gradient to afford N,N-diethyl-N′-[5-(6-chloro-3-cyano-1-methyl-1H-indol-2-yl)-pyridin-3-ylmethyl]-sulfamide as a solid. 1H NMR (400 MHz, MeOD) δ ppm 1.20 (t, J=7.1 Hz, 6H), 3.30 (q, J=7.1 Hz, 4H), 3.83 (s, 3H), 4.35 (s, 2H), 7.38 (dd, J=8.6, 1.8 Hz, 1H), 7.71 (d, J=8.6 Hz, 1H), 7.77 (d, J=1.5 Hz, 1H), 8.17 (t, J=2.1 Hz, 1H), 8.79 (dd, J=3.7, 2.1 Hz, 2H). HRMS (ESI) m/z 432.1278 [(M+H)+ Calcd for C20H23ClN5O2S: 432.1261].

Workup

  1. concentrationThe reaction mixture is concentrated in vacuo
  2. customthe residue is purified by reverse phase HPLC with Xbridge Shield RP18 column

Sources & evidence

ORD record
ord-7df5724d030b4e41a1642d547adb159c
Source dataset
uspto-grants-2014_07
Patent number
US08791141B2

Reaction notes

Loading…